Phenylethylamine Moiety
Phenylethylamine Moiety - Related Videos
03:46
Butyl-Dependant Hydrophobic Interaction Liquid Chromatography: A Technique to Characterize Antibody-Drug Conjugates Based on Hydrophobic Interactions
0 Views •
2025
This video demonstrates the hydrophobic interaction liquid chromatography-based characterization of antibody-drug conjugates. Using a butyl ligand-based chromatography column, the antibody-drug conjugates are characterized via hydrophobic interactions with the ligand.
11:09
Grafting Multiwalled Carbon Nanotubes with Polystyrene to Enable Self-Assembly and Anisotropic Patchiness
0 Views •
Cited by 5 •
2018
A procedure for the synthesis of polystyrene-grafted multiwalled carbon nanotubes using successive chemical modification steps to selectively introduce the polymer chains to the sidewalls and their self-assembly via anisotropic patchiness is presented.
09:26
Synthesis and Characterization of Supramolecular Colloids
0 Views •
Cited by 3 •
2016
A protocol for the synthesis and characterization of colloids coated with supramolecular moieties is described. These supramolecular colloids undergo self-assembly upon the activation of the hydrogen-bonds between the surface-anchored molecules by UV-light.
09:37
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
0 Views •
Cited by 54 •
2009
We present protocols for the 3-dimensional (3D) encapsulation of cells within synthetic hydrogels. The encapsulation procedure is outlined for two commonly used methods of crosslinking (michael-type addition and light-initiated free radical mechanisms), as well as a number of techniques for assessing encapsulated cell behavior.
08:14
Determining Membrane Protein Topology Using Fluorescence Protease Protection (FPP)
0 Views •
Cited by 18 •
2015
Here, we present a protocol to determine the orientation and topology of integral membrane proteins in living cells. This simple protocol relies on selective protease sensitivity of chimeras between the protein of interest and GFP.
FAQs
Substituents can modify lipophilicity, receptor binding, transporter interactions, and vulnerability to monoamine oxidase metabolism. These changes alter how strongly a compound interacts with biological targets and how long its effects may persist. Comparing such substitutions helps pharmacologists connect structural features with potency, selectivity, duration of action, and potential adverse effects.
Susceptibility to monoamine oxidase provides an important metabolic variable. Greater vulnerability can influence how quickly a compound is broken down, whereas altered susceptibility may contribute to differences in duration of action. Evaluating this property alongside receptor and transporter interactions helps explain why related structures can produce different pharmacological profiles.
The scaffold can support compounds that affect different signaling systems, including adrenergic, dopaminergic, or serotonergic pathways. The relevant pharmacological profile depends on structural features that influence receptor binding and transporter interactions. Consequently, closely related molecules may differ in target preference and functional effects, making selectivity a central consideration in pharmacological analysis.
A structure–activity relationship analysis compares chemical modifications with resulting pharmacological properties. Researchers can examine how changes to the aromatic ring or amine affect potency, selectivity, metabolic susceptibility, and duration of action. This approach identifies structural features associated with desirable activity and helps clarify features that may contribute to adverse effects.
Its occurrence in endogenous signaling molecules such as dopamine and in pharmacological agents makes the scaffold useful for studying biologically active compounds. Researchers can evaluate how structural changes influence adrenergic, dopaminergic, or serotonergic signaling. These comparisons support the design and evaluation of medicines intended to produce particular pharmacological profiles.
Comparisons can focus on potency, selectivity, duration of action, receptor binding, transporter interactions, and susceptibility to monoamine oxidase metabolism. Considering these outcomes together provides a broader view than measuring activity alone. The combined profile helps researchers judge whether a structural modification improves pharmacological performance or introduces properties associated with unwanted effects.